Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study

Paul Gillarda Clinical Development, GSK, Wavre, BelgiumCorrespondence[email protected]

Tsuyoshi Tamurab Department of Pediatrics, Hashimoto Clinic, Tokyo, JapanView further author information

Haruo Kurokic Department of Pediatrics, Sotobo Children’s Clinic, Chiba, JapanView further author information

Yoshiyuki Morikawad Pediatrics, Child Support General Clinic, TokyoJapanView further author information

Leentje Moermane Global Regulatory Affairs, GSK, Wavre, BelgiumView further author information

Jose Parraf Clinical Statistics, GSK, Wavre, BelgiumView further author information

Yurina Kitamurag Project Management, Japan Development Division, GSK, Tokyo, JapanView further author information

Kazuko Miharah Medicines Development Division, GSK, Tokyo, JapanView further author information

Arisa Okamasah Medicines Development Division, GSK, Tokyo, JapanView further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.